Factor XI inhibition uncoupled: mechanistic insights and rationale

30 August 2024 (15:30 - 15:40)

Organised by:

Video

Sign in to view the resources

Slides

About the speaker

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)

4 More presentations in this session

Presentation thumbnail

Welcome and Introductions

Professor V. Kunadian (Newcastle-Upon-Tyne, GB)

Presentation thumbnail

Contemporary thrombosis management -- state of the state

Professor V. Kunadian (Newcastle-Upon-Tyne, GB)

Presentation thumbnail

Factor XI inhibition: clinical view on current research and future implications

Professor C. Lam (Singapore, SG)

Presentation thumbnail

Program summary and conclusion

Professor V. Kunadian (Newcastle-Upon-Tyne, GB)

Access the full session

Session thumbnail

Advances in thrombosis management: evaluating current and emerging anticoagulation strategies

The Event

Event poster

ESC Congress 2024

30 August 2024 15:30 CET

You may be interested in

Congress Presentation

Factor XI inhibition – are NOACs obsolete? Mechanistic and pharmacological insights

16 April 2023

Congress Presentation

Sex-specific association of coagulation factor XI with 2-year cardiovascular outcomes in multivessel coronary artery disease: insights into a paradoxical cardioprotective role

30 August 2025

Congress Presentation

Elevated factor XI is associated with left atrial appendage thrombi of unknown origin: links to unfavorable fibrin clot properties

1 September 2025

Congress Presentation

Valvular presence of coagulation factor XI correlates with the severity of aortic stenosis

26 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources